McKesson Total Liabilities 2010-2022 | MCK

McKesson total liabilities from 2010 to 2022. Total liabilities can be defined as the total value of all possible claims against the corporation.
  • McKesson total liabilities for the quarter ending June 30, 2022 were $63.767B, a 1.32% increase year-over-year.
  • McKesson total liabilities for 2022 were $65.09B, a 0.39% increase from 2021.
  • McKesson total liabilities for 2021 were $64.84B, a 15.91% increase from 2020.
  • McKesson total liabilities for 2020 were $55.938B, a 8.86% increase from 2019.
McKesson Annual Total Liabilities
(Millions of US $)
2022 $65,090
2021 $64,840
2020 $55,938
2019 $51,385
2018 $50,324
2017 $49,696
2016 $47,515
2015 $45,785
2014 $41,441
2013 $27,716
2012 $26,262
2011 $23,666
2010 $20,657
2009 $19,074
McKesson Quarterly Total Liabilities
(Millions of US $)
2022-06-30 $63,767
2022-03-31 $65,090
2021-12-31 $64,495
2021-09-30 $63,688
2021-06-30 $62,939
2021-03-31 $64,840
2020-12-31 $62,122
2020-09-30 $55,468
2020-06-30 $52,013
2020-03-31 $55,938
2019-12-31 $54,488
2019-09-30 $52,302
2019-06-30 $53,612
2019-03-31 $51,385
2018-12-31 $51,622
2018-09-30 $51,887
2018-06-30 $51,635
2018-03-31 $50,324
2017-12-31 $52,241
2017-09-30 $52,484
2017-06-30 $50,303
2017-03-31 $49,696
2016-12-31 $50,022
2016-09-30 $48,692
2016-06-30 $48,413
2016-03-31 $47,515
2015-12-31 $46,127
2015-09-30 $46,946
2015-06-30 $46,986
2015-03-31 $45,785
2014-12-31 $45,954
2014-09-30 $41,706
2014-06-30 $42,241
2014-03-31 $41,441
2013-12-31 $28,452
2013-09-30 $27,958
2013-06-30 $28,083
2013-03-31 $27,716
2012-12-31 $25,784
2012-09-30 $25,253
2012-06-30 $24,545
2012-03-31 $26,262
2011-12-31 $25,701
2011-09-30 $24,791
2011-06-30 $24,100
2011-03-31 $23,666
2010-12-31 $23,316
2010-09-30 $19,977
2010-06-30 $20,520
2010-03-31 $20,657
2009-12-31 $20,416
2009-09-30 $19,905
2009-06-30 $19,446
2009-03-31 $19,074
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $50.991B $263.966B
McKesson Corporation is a health care services and information technology company. McKesson operates through two segments: The Distribution Solutions segment distributes branded and generic pharmaceutical drugs along with other healthcare-related products on a global basis worldwide. The segment also provides practice management, technology, clinical support and business solutions to community-based oncology and other specialty practices. In addition, the segment provides specialty pharmaceutical solutions for pharmaceutical manufacturers including offering multiple distribution channels and study access to oncology physicians. The Technology Solutions segment provides enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions. per segment realignment, McKesson reported revenues through four segments: U.S. Pharmaceutical and Specialty Solutions, Internation, Medical-Surgical Solutions and Prescription Technology Solutions.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $72.810B 21.15
AmerisourceBergen (ABC) United States $30.314B 13.39
West Pharmaceutical Services (WST) United States $24.398B 37.15
Laboratory Of America Holdings (LH) United States $23.439B 10.25
Cardinal Health (CAH) United States $16.828B 12.92
Cooper (COO) United States $16.065B 24.73
CONMED (CNMD) United States $2.967B 29.25
Invacare (IVC) United States $0.033B 0.00